NP / PA
Baker, Robetta
Baker, Robetta was paid $1.39M by Medicaid between Oct 2019 and Dec 2024, across 16 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 40% of everything it billed.
33Billing provider infoBAKER, ROBETTA
HAZARD, KY 41701
HAZARD, KY 41701
33aNPI1043590227assigned 08/19/2011
33bProvider typeFamily Nurse Practitioner
28Total paid$1.39M
24GClaims43,075
24DCodes billed16
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Kentucky
Rank by total paid#13 of 424
Median peer was paid$19K
This provider vs. median74×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 86 | $2K | |
| 2020 | 11,981 | $467K | |
| 2021 | 9,687 | $277K | |
| 2022 | 7,758 | $215K | |
| 2023 | 7,323 | $223K | |
| 2024incomplete | 6,240 | $209K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 40% | 18,469 | 15,752 | $564K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 18% | 1,530 | 1,469 | $251K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 9,598 | 8,251 | $209K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 9.7% | 1,700 | 1,582 | $135K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.0% | 3,719 | 3,204 | $126K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.4% | 4,188 | 3,724 | $75K |
| 72131 | 1.2% | 240 | 192 | $16K | |
| 72192 | <1% | 99 | 90 | $10K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 38 | 36 | $5K |
| 99243 | <1% | 33 | 24 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 129 | 107 | $88.76 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 908 | 684 | $1.24 |
4 more codes
| G9578 | Documentation of signed opioid treatment agreement at least once during opioid therapy | <1% | 917 | $0.21 |
| G9583 | Patients prescribed opiates for longer than six weeks | <1% | 899 | $0.21 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 513 | $0.00 |
| G9562 | Patients who had a follow-up evaluation conducted at least every three months during opioid therapy | 0% | 95 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.